https://mail.innovareacademics.in/journals/index.php/ijpps/issue/feed International Journal of Pharmacy and Pharmaceutical Sciences 2024-11-01T12:05:41+0530 Editor editor@ijppsjournal.com Open Journal Systems <div align="justify"> <div align="justify"> <p>International Journal of Pharmacy and Pharmaceutical Sciences (Int J Pharm Pharm Sci) is a peer-reviewed, open-access journal published monthly (April 2014). IJPPS publishes original research work as original articles or short communications, significantly advancing scientific knowledge in pharmacy and pharmaceutical sciences. The journal also considers articles on the current and trending subject, provided they match the current research needs and possess scientific impact.</p> <p>The scope of the journal encompasses the following</p> <ul> <li>Pharmaceutical Technology, Pharmaceutics, Novel Drug Delivery, Biopharmaceutics, Pharmacokinetics</li> <li>Pharmacognosy and Natural Product Research</li> <li>Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmaceutical Analysis</li> <li>Pharmacology, Toxicology, Pharmacy Practice, Clinical and Hospital Pharmacy</li> <li>Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics, Pharmacoeconomics.</li> <li>Case studies cover the treatment with medicine.</li> <li>Biotechnological studies of pharmaceutical interest.</li> <li>Research outcomes of endemic/pandemic situations</li> </ul> <p>Since March 2016, the journal has also started considering hypotheses; however, the frequency is limited.</p> </div> </div> https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52010 DEVELOPMENT OF NOVEL SINGLE HPLC METHOD FOR SIMULTANEOUS SEPARATION OF MULTIPLE IMPURITIES IN DEXAMETHASONE DRUG PRODUCT 2024-07-09T11:55:49+0530 JIGESH H. SHAH jigesh123@yahoo.co.in TUSHAR MEHTA tusharm@amneal.com AMIT MUKHARYA amit.mukharya@amneal.com ANIRBAN ROY CHOWDHURY anirbanc@amneal.com AJAY PATEL ajayp@amneal.com SANJAY MEVADA sanjay.mevada@amneal.com B. T. THAKER btthaker1@yahoo.co.in RAKSHIT AMETA rakshit_ameta@yahoo.in <p><strong>Objective: </strong>A simple, reliable, and rapid HPLC method has been established for the detection of Dexamethasone (DEX) and its related impurities. The proposed method has been validated for specificity, linearity, system suitability, accuracy, precision, robustness, LOD, and LOQ as per International Council for Harmonisation (ICH) guidelines. All parameters were found to be within the accepted limits, affirming the method's reliability.</p> <p><strong>Methods: </strong>Analysis was conducted using HPLC on X-Bridge C18 column (250 mm×4.6 mm id, 3.5 µm) with a mobile phase-A comprising buffer and acetonitrile (90:10, v/v), mobile phase-B comprising buffer and acetonitrile (25:75, v/v) and a flow rate of 0.8 ml/min by following gradient elution. The detection was performed with a UV detector set at 240 nm. The method has been employed to investigate DEX and DEX-related impurities. These studies were conducted in tablet formulations of DEX.</p> <p><strong>Results: </strong>The Retention Time (tR) of DEX was about 41.589 min, and all parameters met acceptable limit values. The response exhibited linearity over a concentration range of 0.162 to 3.052 µg/ml (R<sup>2</sup>= 0.9999). The percentage of DEX recovered from the pharmaceutical tablet dosage form ranged from 96.3 % to 100.4 %. Sensitivity levels for the developed method were indicated by LOD and LOQ values of 0.081–0.162 µg/ml. The proposed method was validated according to ICH guideline.</p> <p><strong>Conclusion: </strong>Hence, a simple, reliable, accurate, and precise HPLC method was developed, proving suitable for the separation of DEX and DEX-related impurities in commercial formulations.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 JIGESH H. SHAH, TUSHAR MEHTA, AMIT MUKHARYA, ANIRBAN ROY CHAUDHARY, SANJAY MEVADA, SANJAY MEVADA, B. T. THAKER, RAKSHIT AMETA https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52366 Article Withdrawn 2024-08-16T08:22:07+0530 <p>This article has been withdrawn from publication on author’s request</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 Article Withdrawn https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52381 ANTIDEPRESSANT-LIKE ACTIVITY OF AQUEOUS EXTRACT OF ROSA DAMASCENA IN MICE 2024-08-17T15:33:05+0530 JAMALUDDIN SHAIKH jamaluddin@unizwa.edu.om AFAF MOHAMMED WELI afaf@unizwa.edu.om SADRI ABDULLAH SAID sadri@unizwa.edu.om <p><strong>Objective: </strong>Plant-based drugs have the potential to be very effective substitutes for prescription antidepressants. <em>Rosa damascena</em> has therapeutic potential as an analgesic, anticonvulsant, antitussive, bronchodilatory, antibacterial, anti-diabetic, anti-inflammatory, antioxidant, and laxative. Given this context, the goal of the current study was to assess <em>Rosa damascena</em>'s potential antidepressant effects.</p> <p><strong>Methods: </strong>Maceration was used to create an aqueous extract of <em>Rosa damascena</em>. The Tail Suspension Test (TST) on BALB/c mice and the Forced-Swimming test (FST) on C57BL/6 mice were used to quantify the antidepressant activity. Mice were divided into three groups: control (saline), standard (citalopram and desipramine), and <em>Rosa damascena</em> aqueous extract (n = 6 per group). Intraperitoneally (1 ml/100 g) injections of drugs were administered. Analysis of variance was used to examine the data, and then LSD post-hoc tests were performed. The data are expressed as mean±SEM.</p> <p><strong>Results: </strong>Antidepressant-positive controls, citalopram and desipramine, significantly decreased the time of immobility in the FST and TST as compared to the vehicle control group (p&lt;0.001). In FST, the immobility durations were significantly reduced by the <em>Rosa damascena</em> aqueous extract at a dose of 40 mg/kg compared to lesser doses of the same extract (10 and 20 mg/kg) (p&lt;0.001). Similarly, the 40 mg/kg dose of <em>Rosa damascena</em> aqueous extract significantly reduced the length of immobility in TST (p&lt;0.001).</p> <p><strong>Conclusion: </strong>The present findings demonstrate <em>Rosa damascena</em>'s antidepressant-like effects in mice. Further research is necessary to determine the underlying mechanism by which <em>Rosa damascena</em> generates effects akin to those of an antidepressant in light of this observation.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 JAMALUDDIN SHAIKH, AFAF MOHAMMED WELI, SADRI ABDULLAH SAID https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52414 PREBIOTIC EFFICACY OF DEFATTED FENUGREEK SEED FLAKES (FENUFLAKESTM): A SHORT-TERM COLONIC SIMULATION STUDY 2024-08-23T14:35:27+0530 PRASAD THAKURDESAI prasad@indusbiotech.com PALLAVI DESHPANDE pallavi@indusbiotech.com SAVITA NIMSE savita@indusbiotech.com SUNIL BHASKARAN sunil@indusbiotech.com MADHURA KARVE madhura.karve@indusbiotech.com DHANANJAY RAJE dvraje@gmail.com <p><strong>Objective: </strong>To investigate the prebiotic effects of defatted fenugreek seed flakes (Fenuflakes™) using a 48-hour colonic simulation model.</p> <p><strong>Methods: </strong>Fecal samples from three healthy adult human donors were exposed to treatment conditions of blank (medium control), Fenuflakes, or inulin (fiber control). The effects on microbial fermentation (pH and gas production), metabolite production [Short Chain Fatty Acid (SCFAs), Branched-Chain Fatty Acid (BCFA), ammonium and lactate production], and microbial community composition were evaluated at 0, 6, 24, and 48 h.</p> <p><strong>Results: </strong>In comparison to inulin, Fenuflakes demonstrated a significant reduction in gas production. Both inulin and Fenuflakes significantly increased beneficial SCFAs, but no significant change was observed in BCFA. Ammonium production increased upon Fenuflakes treatment due to a residual protein fraction reaching the colon, in contrast to inulin, which is in a protein-depleted state. The lactate levels significantly increased for Fenuflakes and inulin. The presence of Fenuflakes and inulin resulted in favorable fermentation by the colonic gut microbiota, indicating an increase in species enrichment and alpha diversity in the microbial community composition.</p> <p><strong>Conclusion: </strong>Fenuflakes exhibit prebiotic potential by increasing SCFA and promoting the enrichment of several beneficial colonic bacteria while maintaining normal colonic pH and producing less gas than inulin.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 PRASAD THAKURDESAI, PALLAVI DESHPANDE, SAVITA NIMSE, SUNIL BHASKARAN, DHANANJAY RAJE, MADHURA KARVE https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52671 IS ONLINE SEARCH FOR MEDICATION INFORMATION WILL BECOME A NEW DIMENSION FOR NONCOMPLIANCE 2024-09-15T22:22:57+0530 GIRISH P. girish23.mpc@gmail.com CHALIKI SUNIL CHOWDARY sekharpharma9@gmail.com SANDEEP sandykasina1@gmail.com BODDU V. S. CHANDRASEKHAR sekharpharma9@gmail.com <p><strong>Objective: </strong>The aim of the present study was to investigate the effect of online medication information on adherence and beliefs with chronic illness.</p> <p><strong>Methods: </strong>The study was carried out at a tertiary-care teaching hospital. A questionnaire was used to assess beliefs on the online information, stopped the medication without consultation, missed dose based on information on online, trust on information provided by the health care provider, type and frequency of the online search information on medications and finally, adhere to the medication regimen.</p> <p><strong>Results: </strong>A total of 95 participants were interviewed and 60 participants were showed interest to participate in the study. Chronic illness conditions among them were mostly hypertension, diabetes milletus followed by asthma and COPD, renal failure, inflammation and convulsions. Seeking online health information 30% daily, 33% weekly, monthly 10%, rarely 16% never 10%. The information mostly searched around 40% of treatment options, 35% of medication information and flowed by disease symptoms, dietary advises and physical exercises. Belief on online information was 66.7% positively and 33.3 negatively. Trust on healthcare provider about medication information the complete trust 60%, somewhat trust 38.30%, not trust was 1.6%. Only 15% subjects felt difficulty to adhere to medication regimen.</p> <p><strong>Conclusion: </strong>Despite of participants searching for online health information, still they have strong belief on prescription and medication adherence.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 DR GIRISH P, , CHALIKI SUNIL CHOWDARY, SANDEEP, BODDU V. S. CHANDRASEKHAR https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52107 VARIATIONS IN VOLATILE OIL CONSTITUENTS OF ECHINOPS SPECIES GROWING IN THE MIDDLE EAST AND THE MEDITERRANEAN REGIONS: MINI REVIEW 2024-07-21T15:31:53+0530 GHINA ABDUL MAJID ghinaabdulmajid@gmail.com MOHAMAD ALI HIJAZI mahaaboulela1@gmail.com ABDALLA EL LAKANY abdalla@bau.edu.lb MAHA ABOUL ELA mahaaboulela1@gmail.com <p>The genus Echinops of the family Asteraceae has commonly been a subject of interest because its members have various chemical constituents and crucial pharmacological activities of great medicinal importance over the last decade (2010-2023). Therefore, this genus has attracted serious research in pharmacognosy and herbal medicine. Detailed studies revealed that Echinops species contain numerous bioactive compounds, such as sesquiterpene lactones, essential oils, flavonoids, and polyacetylenic aliphatic acids, largely in plant parts that are important for therapeutic use. These bioactive constituents have been associated with a wide diversity of pharmacological activities such as anti-inflammatory, antimicrobial, and cytotoxic underlined while proceeding to show some antioxidant activity and even hepatoprotective action of the genus, hence encouraging the further development of novel therapeutic agents. Most of these activities have been studied both <em>in vitro</em> and <em>in vivo</em> to establish their underlying effects. This will help us evaluate pharmacological properties attributed to the genus Echinops and pave the way for future studies to validate traditional uses and optimize extraction methods and their clinical applications. This work highlighted the position of Echinops species in Mediterranean areas, especially essential oils as a source of bioactive compounds useful in the well-being of humans and its variation concerning several factors. It has reaffirmed the place of natural products in drug discovery and development.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 GHINA ABDUL MAJID, MOHAMAD ALI HIJAZI, ABDALLA EL LAKANY, MAHA ABOUL ELA https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52382 UNDERSTANDING THE BENEFITS OF STEVIA REBAUDIANA BERTONI FOR DIABETES: A COMPREHENSIVE REVIEW 2024-08-17T23:27:17+0530 B. DHARANI doctordharanibhaskaran@gmail.com SUBA A angappansuba@gmail.com STEPHY SEBASTIAN drstephy06@gmail.com <p>Diabetes Mellitus (DM) is a complicated metabolic condition defined by long-term elevated blood glucose levels. This chronic hyperglycemia induces metabolic dysfunctions that cause structural and functional disruptions in the vasculature, leading to macrovascular and microvascular complications. <em>Stevia rebaudiana Bertoni</em>, commonly known as <em>Stevia</em>, is a perennial shrub that contains various bioactive constituents responsible for its sweetness and several other activities. Many studies on <em>Stevia</em> have shown that it possesses various beneficial effects on health, including being zero-calorie, anti-obesity, anti-diabetic, anti-hypertensive, antioxidant, antimicrobial and anti-tumor. Several studies have found that neither gastric juice nor digestive enzymes decompose stevioside. The presence of bioactive phenolic and flavonoid compounds supports <em>Stevia's</em> medicinal properties and its potential use in both the food/nutraceutical and pharmaceutical industries. A significant antioxidant capacity of <em>Stevia</em> has been identified recently. It can also help limit essential nutrient supply to tumor cells. Research on <em>Stevia's</em> effects on the human body has largely found no negative side effects. The growing body of evidence underscores <em>Stevia's</em> potential role in managing various health conditions, particularly for diabetic patients, due to its minimal impact on blood sugar levels. However, to fully harness its benefits and meet the increasing global demand, further scientific research is essential to optimize its cultivation, enhance its chemical constituents and ensure its safety. Overall, <em>Stevia</em> stands out as a promising natural sweetener with significant health benefits for diabetic patients. In this review article, we explore different aspects of <em>Stevia</em> and its beneficial effects on diabetic patients.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 B. DHARANI, SUBA A, STEPHY SEBASTIAN https://mail.innovareacademics.in/journals/index.php/ijpps/article/view/52092 OPTIMIZING DRUG DOSING IN CRITICALLY ILL PATIENTS WITH AUGMENTED RENAL CLEARANCE: A COMPREHENSIVE REVIEW AND META-ANALYSIS 2024-07-18T19:02:07+0530 MIHIR CHACHAR mchachar143@gmail.com TALLINI LOKHANDE tallinidl12@gmail.com ANJALI KUMBHAR dranjali5995@gmail.com ROHINI CHAVAN drrohinichavan33@gmail.com DHANRAJ SHINDE pddhanrajshinde@gmail.com <p>Renal clearance plays a pivotal role in eliminating most administered drugs, particularly antibiotics, which is crucial for achieving therapeutic goals by maintaining plasma concentrations within the therapeutic window. Various pre-existing conditions such as renal replacement therapies, kidney or liver impairment, and enhanced excretory organ function can disrupt drug concentrations, leading to treatment failure. Augmented Renal Clearance (ARC) exacerbates this by causing rapid drug elimination, notably in critically ill patients. Consequently, careful monitoring and adjustment of drug dosages tailored to individual patient conditions and comorbidities are imperative to prevent sub-therapeutic outcomes or treatment failures. Our review highlights the necessity of dosage modifications informed by current research to optimize therapeutic outcomes in such cases. We provide a comprehensive table detailing effective antibiotics and their adjustments for ARC.</p> 2024-11-01T00:00:00+0530 Copyright (c) 2024 ANJALI KUMBHAR, MIHIR CHACHAR, TALLINI LOKHANDE, ROHINI CHAVAN, DHANRAJ SHINDE